FDA Medical Device 510(k) Submission for PLTenus Platelet-rich Plasma Injection

Program: Applied Biotechnology Master's Degree — Research and Development
Host Company: TCM Biotechnology
Location: Taipei, Not Specified (remote)
Student: Catherine Wang

The objective of this capstone is to plan for the FDA 510(k) approval for PLTenus Platelet-rich plasma injection. This project plan will be provided all the information and preparation required for TCM Biotech to submit FDA 510(k) for their PRP product.